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Abstract
Crystals of cytochrome bo3 ubiquinol oxidase from E. coli diffract X-rays to 3.5 Aî and the structure determination is in
progress. The limiting factor to the elucidation of the structural detail is the quality of the crystals ; the diffraction spots from
the crystals are diffused which leads to difficulties in processing the data beyond 4.0 Aî . Weak protein^protein contacts within
the crystal lattice is assumed to be the cause of this problem. To improve these contacts, we have introduced protein Z to the
C-terminal end of the subunit IV of cytochrome bo3 and expressed both proteins as a single fusion. We have successfully
obtained crystals of this fusion protein. The spot shape problem has clearly been solved in the crystals of the fusion protein
although further optimization is necessary to obtain higher resolution. We also discuss the potential applications of this
approach to the crystallization of membrane proteins in general. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Heme^copper oxidases are integral membrane pro-
teins located in the inner membrane of the mitochon-
dria or the bacterial inner membrane. The oxidases
are the ¢nal electron acceptors in the respiratory
chain and catalyze the reduction of molecular oxygen
to water. The terminal oxidases are divided into two
variants based on substrate speci¢city: cytochrome c
oxidases from mitochondria and many bacteria use
cytochrome c as a substrate whereas some bacterial
terminal oxidases utilize membrane-bound quinol as
a substrate, and are thus called quinol oxidases.
Both cytochrome c and quinol oxidases have been
extensively studied by biochemical and biophysical
methods (for recent reviews see [1,2]). In recent years,
there has been a great deal of progress in functional
studies on cytochrome c oxidase, mainly due to the
crystal structures [3^6]. Proton pumping mechanisms
based on these structures have been extensively dis-
cussed, although no de¢nitive conclusion has been
obtained. In order to increase our understanding of
this pumping mechanism and to study the ubiqui-
none binding site, we are studying cytochrome bo3
ubiquinol oxidase from Escherichia coli. We have
obtained crystals of cytochrome bo3 [7] and structure
determination is in progress (manuscript submitted).
However, the work has been hampered by the qual-
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ity of the crystals: the di¡raction spots from the
crystals show strong di¡usion which causes di⁄cul-
ties in processing the data beyond 4.0 Aî . The weak
protein^protein contact in the crystal lattice is as-
sumed to cause a disorder of the crystal leading to
the di¡used di¡raction spots. Typically for mem-
brane proteins, the cytochrome bo3 crystal has a
high solvent content (60%) due to the large detergent
micelle surrounding the protein. Protein^protein con-
tact in the membrane protein crystal lattice takes
place mainly at the hydrophilic surfaces since the
hydrophobic surfaces are covered by detergent mi-
celles. This has proven to be the case for cytochrome
bo3 crystals [7].
In order to elucidate the precise details of the pro-
ton pumping mechanism of cytochrome bo3, it is
necessary to improve crystal quality. To achieve
this aim, we investigated the possibility of increasing
protein^protein interaction within the crystal lattice
by extending the hydrophilic domain cytochrome
bo3. To obtain crystals of cytochrome c oxidase
from Paracoccus denitri¢cans, an antibody FV frag-
ment was used for this purpose [8]. For our study, we
generated a fusion protein of cytochrome bo3 and
protein Z. Protein Z, a modi¢ed form of the frag-
ment B of protein A of Staphylococcus aureus, is a
small, highly soluble and highly stable protein [9,10].
In addition, a high-resolution structure of the frag-
ment B of protein A is available [11]. The protein Z
was fused to the C-terminal, extracellular end of sub-
unit IV of cytochrome bo3 that is adjacent to the
large solvent ¢lled gap within the crystal lattice struc-
ture. The position of protein Z within the fusion
protein is designed to improve the protein^protein
contact in the crystals based on the packing of the
wild-type cytochrome bo3 crystals. In this paper, we
present the crystallization and preliminary crystallo-
graphic studies of this fusion protein. We also discuss
the potential applications of this approach to the
crystallization of membrane proteins in general.
2. Materials and methods
2.1. Materials
Oligonucleotides were obtained from Scandinavian
Gene Synthesis and Genset Oligos, France. All poly-
merase chain reactions (PCRs) were performed using
Advantage Taq (Clontech) and dNTP (Boehringer
Mannheim, Bromma, Sweden). PCR products were
puri¢ed using the Qiagen gel puri¢cation kit (Qiagen,
Hilden, Germany) and cloned into the pCR 2.1
TOPO vector (Invitrogen, Groningen, Netherlands).
All constructs were sequenced using a 377 DNA se-
quencer (ABI) and the sequences analyzed using the
program Vector NTI (Informax, Bethesda, MD,
USA). Restriction endonucleases were obtained
from Boehringer Mannheim and T4 DNA ligase
from New England Biolabs (Hitchin, UK). DNA
was prepared from E. coli cultures using plasmid
miniprep kits from Qiagen or plasmid midiprep kits
from Promega (Madison, WI, USA). The GasPack
100 anaerobic system and GasPack Plus envelopes
were obtained from Becton Dickinson (Stockholm,
Sweden). The peroxidase anti-peroxidase conjugate
was purchased from Dako (Glostrup, Denmark)
while nitrocellulose and the ECL detection kit were
bought from Amersham Pharmacia Biotech (Upp-
sala, Sweden). Detergents were purchased from Ana-
trace (Maumee, OH, USA), Ni2+NTA resin from
Qiagen and the MonoQ column from Amersham
Pharmacia Biotech.
2.2. Insertion of unique restriction sites to the
C-terminal of subunit IV
The pMB908 (pJRHisA) was a gift from Professor
R. Gennis, University of Illinois, Urbana, IL, USA.
This construct consists of pBR322 into which the
whole cytochrome bo3 operon has been cloned, in-
cluding a His9-tag at the end of cyoA, yielding a
plasmid of approximately 10 kb in size. The addition
of unique restriction sites (MCS) to the 3P end of
subunit IV in pMB908 was performed by the PCR
method of splicing by overlap extension as previously
described [12]. Brie£y, the method entails the use of
four di¡erent primers, two encompassing the entire
sequence to be changed (5P-TTCACGAACGT-
GATGCATTCTGGGTTTTGA-3P and 5P- CTCCT-
TGCATGCGCAAGCCGCATACGGTCC-3P), one
on either end of the new construct, and two centrally
positioned primers (5P-GCACAGCGGCCGCGAG-
CTCACGCGTATGTCTAGATAAGAGCGGCG-
GTTATG-3P and 5P-ATCTAGACATACGCGTGA-
GCTCGCGGCCGCTGTGCATCACATGTTGTA-
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3P) containing the sequence for the restriction sites
(NotI, SacI, MluI, XbaI) giving rise to two fragments
containing overlapping sequences. These two frag-
ments were then used as template in order to amplify
the full-length 2.4 kb fragment incorporating the
MCS. This was then ligated into pMB908 generating
pMB930.
2.3. Generation of cytochrome bo3+protein Z fusion
protein
Protein Z was ampli¢ed from the commercially
available vector pEZZ-18 (Amersham Pharmacia
Biotech) using oligonucleotide sequences (5P- GCG-
GCCGCGACAACAAATTCAACAAAGAACAAC-
AAAAT-3P and 5P-TGATGCTCAGGCGCCGAA-
AGTAACGCGT-3P) which code for a NotI site at
the 5P end and MluI site at the 3P end, respectively.
The PCR fragment was cloned into pMB930 to yield
the vector construct pMB1048.
2.4. Expression of cytochrome bo3+protein Z fusion
protein
The DNA coding for cytochrome bo3+protein Z
fusion was transformed into a terminal oxidase de¢-
cient E. coli strain, GO105 [13], which will only grow
under aerobic conditions after introduction of a
functional cytochrome bo3. The GO105 cells were
grown anaerobically in a BBL GasPack 100 anaero-
bic system using GasPack Plus envelopes and made
competent using standard methods [14]. Colonies ob-
tained were used to inoculate 10 ml of LB supple-
mented with ampicillin which were incubated over-
night at 37‡C. The speci¢c expression of subunit
IV+Protein Z was assessed by Western blot analysis
using a method based on the one described by Ron-
dahl et al. [15] using peroxidase anti-peroxidase as a
substrate. For the large-scale expression, GO105 cells
expressing the fusion protein were grown in a 10-liter
fermentor (OD550 = 3.0), according to the method de-
scribed previously [16].
2.5. Puri¢cation and crystallization of cytochrome
bo3+protein Z
Membrane preparation and protein puri¢cation
was performed as described previously [7]. Crystals
for this fusion protein were obtained by the hanging-
drop vapor di¡usion technique under similar condi-
tions to the wild-type cytochrome bo3 [7]. The en-
zyme solution contained 20 mM Tris^HCl bu¡er
(pH 7.5) with 1% octylglucoside and 20 mg/ml pro-
tein. A reservoir solution of 7^8% (w/v) PEG 1500,
100 mM NaCl, 100 mM MgCl2, 100 mM Hepes^
NaOH (pH 7.0) and 5% ethanol was used. The pro-
tein solution was mixed in a 1:1 ratio with the res-
ervoir solution and left to equilibrate at 10‡C.
2.6. Data collection and processing
Data was collected from frozen crystals. Prior to
freezing the crystals in liquid nitrogen they were
soaked in cryo-solutions in which both the glycerol
and PEG 1500 concentrations were gradually in-
creased. Data was collected at the ESRF (European
Synchrotron Radiation Facility) on beamline ID14/
EH4. Data collection was performed at 100 K. Im-
age data were processed by the HKL program suite
[17].
3. Results
3.1. Expression of cytochrome bo3+protein Z
We were able to assess the expression of cyto-
chrome bo3+MCS and cytochrome bo3+protein Z
in two ways. Firstly, transforming the modi¢ed
forms of cytochrome bo3 into the terminal oxidase
de¢cient strain, GO105, gave colonies which grew
under exactly the same conditions as those trans-
formed with wild type bo3. Expression of the cyto-
chrome bo3+MCS construct was further assessed by
western blot analysis using an anti-His antibody di-
rected against the His tag at the C-terminal end of
subunit II. This construct yielded a strong and spe-
ci¢c band corresponding to subunit II (33 kDa)
which was identical to that seen for the native bo3
control (Fig. 1A). Western blot analysis of cyto-
chrome bo3+protein Z fusion probed with peroxidase
anti-peroxidase which binds to protein Z, yielded a
strong and highly speci¢c band of approximately 21
kDa which was not present in the negative control of
cytochrome bo3 only (Fig. 1B). Large-scale expres-
sion of cytochrome bo3+protein Z construct was per-
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formed over about 8 h and showed a similar growth
pattern to the native cytochrome bo3.
3.2. Puri¢cation and crystallization of cytochrome
bo3+protein Z
Cytochrome bo3+protein Z fusion protein was pu-
ri¢ed under the same conditions as the wild-type en-
zyme [7]. Both ‘low’ and ‘high’ imidazole fractions
yielded crystals under similar conditions to the wild-
type enzyme. However, the crystals of the fusion
protein were obtained over a wider pH range (6^8)
than the wild type’s (pH 7^7.5). The external appear-
ance of the crystals for both ‘low’ and ‘high’ imida-
zole fractions were almost identical but clearly di¡er-
ent from that of the wild-type cytochrome bo3 (Fig.
2). The crystals of the fusion protein have a more
regular shape than the wild-type crystals. The shape
of the di¡raction spots from the fusion protein have
been signi¢cantly improved; however the resolution
of the crystals has been decreased from the wild-type
crystals (Fig. 3). We have collected a data set from a
crystal of the fusion protein which di¡ract X-rays up
to 6 Aî . The crystal belong to the space group P21
with the cell dimensions of a = 93.4 Aî , b = 328.7 Aî ,
c = 131.1 Aî and L* = 92.1‡. The data set was pro-
cessed to 6 Aî resolution with an overall completeness
of 79% (69% in the outer shell) using 26 844 re£ec-
tions (15 665 unique). The Rmerge values in the lowest
(100^11.9 Aî ) and highest (6.3^6.0 Aî ) resolution shells
are 0.029 and 0.45, respectively with the overall
Rmerge value being 0.045. Assuming a tetramer of
cytochrome bo3 (Mr = 576 kDa) per asymmetric
unit, the ratio of the volume to unit protein mass
(VM) and the solvent content of a crystal are 3.5
Aî 3/Da and 60%, respectively. The space group of
the crystals are di¡erent from the wild-type crystals.
These crystals belong to the space group C2221 with
the cell dimensions of a = 91.3 Aî , b = 370.3 Aî and
c = 232.4 Aî ; the VM and solvent contents are 3.4
Aî 3/Da and 59%, respectively. Some of the cell pa-
rameters and solvent contents of the fusion protein
Fig. 2. Crystals of cytochrome bo3 ubiquinol oxidase from E.
coli. (a) A wild-type crystal. The size of the crystal is of
0.6U0.2U0.1 mm. (b) Crystals for cytochrome bo3+protein Z
fusion. The size of the largest crystal is 0.3U0.4U0.1 mm.
Fig. 1. Western blot analysis of membranes prepared from
GO105 cells expressing wild-type and modi¢ed forms of cyto-
chrome bo3. Blot A was probed with an anti-His antibody spe-
ci¢c to the His tag sequence at the C-terminal end of subunit
II and shows a speci¢c band corresponding to subunit II for
both the wild-type form of cytochrome bo3, 908, and the cyto-
chrome bo3 with the MCS, 930. Blot B was probed with peroxi-
dase anti-peroxidase and shows a clear band corresponding to
subunit IV+protein Z for 1048 which is not present for 908.
This blot also shows the speci¢c band obtained for puri¢ed
1048 diluted 1:20 000.
BBABIO 44938 7-8-00 Cyaan Magenta Geel Zwart
B. Byrne et al. / Biochimica et Biophysica Acta 1459 (2000) 449^455452
crystals are similar to those for the wild type. As
mentioned above, the conditions under which crys-
tals were obtained for the fusion protein were also
similar to those for the wild-type cytochrome bo3.
This indicates that the packing of the wild-type and
fusion protein crystals could be related. Unfortu-
nately molecular replacement trials have not been
successful so far, since the new crystal form has
four fusion proteins in the asymmetric unit, com-
pared with two for the wild-type, and the data reso-
lution is limited.
4. Discussion
The crystal packing of the wild-type cytochrome
bo3 has been determined by molecular replacement;
the lattice has been shown to contain large solvent
¢lled gaps adjacent to the C-terminal end of subunit
IV (Fig. 4). This space is a partly ¢lled with solvent
and partly ¢lled with the detergent micelle around
the protein. In an attempt to increase protein^protein
contact in the cytochrome bo3 crystals, we fused pro-
tein Z to the C-terminal end of subunit IV of cyto-
chrome bo3. The C-terminus of subunit IV is posi-
tioned on the periplasmic side of the cell ; thus,
protein Z, which is readily secreted and stable, was
an ideal fusion partner. The fusion protein was de-
signed in such a way as to place protein Z in the
solvent ¢lled gap, thus allowing it to make a contact
with the next cytochrome bo3 in the crystal lattice
(Fig. 4). The fusion protein expressed readily in an
E. coli deletion strain demonstrating that the pres-
ence of the Protein Z had not a¡ected the expression,
folding or function of cytochrome bo3. In addition
the growth characteristics of the fusion protein under
large-scale expression conditions was similar to the
wild-type cytochrome bo3 although the overall ex-
pression was slightly increased. Similar to the wild-
type cytochrome bo3, the puri¢cation of the fusion
protein on the Ni-NTA column yielded high and low
imidazole peaks [7]. It is thought that partial and
speci¢c proteolysis of the C-terminus of the subunit
II including His9 is responsible for the elution of the
¢rst protein peak at such low concentrations of imi-
dazole. However, in contrast to the wild-type cyto-
chrome bo3, cytochrome bo3+protein Z consistently
yielded crystals for both the high and low imidazole
protein fractions.
In principle, the method of developing a fusion
protein worked; crystals of the fusion protein were
obtained under very similar conditions to the wild-
type cytochrome bo3. We were able to achieve our
¢rst objective; the di¡raction spots do not exhibit the
Fig. 3. X-Ray di¡raction patterns of (a) a wild-type crystal around 4 Aî resolution and (b) a crystal of cytochrome bo3+protein Z fu-
sion around 6 Aî . Both data were collected at the beam line ID14/EH4 of ESRF. Exposure time and oscillation range are 5 s and
0.3‡, respectively.
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di¡usion seen for the wild-type crystals (Fig. 3).
However, two unexpected things happened; the
space group for the fusion protein crystals is di¡er-
ent, although it appears to be related to that of the
wild-type crystals and the fusion-protein crystals ex-
hibit decreased resolution compared with the wild-
type crystals. The change of the space group should
be due to the change of the protein^protein contact
of the crystal caused by introduction of protein Z.
On the other hand, this clearly indicates that the
protein Z is, indeed, involved in the protein^protein
contact in the lattice. The loss of the resolution could
also be related to the rearrangement of the packing.
It is known that detergent selection is very important
in order to obtain well di¡racting membrane protein
crystals; the detergent whose micelles ¢t best into the
solvent gap within the crystal lattice is assumed to
give the best crystals. Since the shape of the solvent
gap is altered by the presence of the protein Z, the
optimal detergent may be di¡erent for crystals of the
Fig. 4. Packing of the wild-type cytochrome bo3 crystal. One molecule of cytochrome bo3 is highlighted using thick lines. The subunit
IV and other subunits of the highlighted molecule are in magenta and in green, respectively. The position of the C-terminus of the
subunit IV is labeled as ‘C’. All other symmetrically related molecules are drawn using light-blue thin lines. The dotted circle shows
the approximate size and position of the protein Z when it is fused at the C-terminus of the subunit IV. The ¢gure was produced us-
ing the program O [18].
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fusion protein. We are currently screening to identify
the detergent that will yield crystals that di¡ract to
the highest possible resolution. In addition, we are
also experimenting with alternative fusion partners
The solvent-¢lled gaps within membrane protein
crystals are quite large. The gap in the cytochrome
bo3 crystal lattice is as large as 100 kDa. Thus, it may
be possible to apply this principle to the fusion of
other larger protein molecules to the C-terminus of
subunit IV. This method could be useful not only for
improving the quality of the membrane protein crys-
tals but for the e¡ective crystallization of other pro-
teins including integral membrane proteins. The lim-
itation is that the protein of interest must express in
E. coli with its N-terminus on the extracellular side.
In spite of this limitation, the approach could be
applied to some interesting proteins including the
G-protein coupled receptors. We are currently inves-
tigating this possibility.
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